19例原发性肝癌心脏转移患者超声特征表现和预后分析*

doi:10.3969/j.issn.1672-5069.2022.02.030

实用肝脏病杂志 ›› 2022, Vol. 25 ›› Issue (2): 271-274.doi: 10.3969/j.issn.1672-5069.2022.02.030

19例原发性肝癌心脏转移患者超声特征表现和预后分析^*

王连双, 张瑶, 单涛, 张记, 吕志斌, 薛明

100015 北京市首都医科大学附属北京地坛医院超声科

收稿日期:2021-03-20 出版日期:2022-03-10 发布日期:2022-03-15
通讯作者: 张瑶,E-mail:zgzs007@163.com
作者简介:王连双,男,38岁,医学硕士,副主任医师。E-mail:wanglianshuang99@163.com
基金资助:
*北京市医管中心培育计划项目(编号:PX2019803)

Ultrasonographic feature and prognosis of patients with hepatocellular carcinaoma and cardiac metastases: Analysis of 19 cases

Wang Lianshuang, Zhang Yao, Shan Tao, et al

Department of Ultrasonography, Ditan Hospital, Capital Medical University, Beijing 100015, China

Received:2021-03-20 Online:2022-03-10 Published:2022-03-15

摘要/Abstract

摘要： 目的总结肝细胞癌(HCC)心脏转移的超声表现特征,并分析其预后。方法 2013年1月～2019年5月我院收治的19例HCC心脏转移患者,回顾分析患者心脏超声表现,总结其特征,并随访其预后。结果 16例(84%)在肝癌相邻的肝静脉内可见实性回声,并延续至下腔静脉和右心房,3例(16%)肝癌相邻下腔静脉内可见实性回声,并延续至右心房; 13例(68%)为混合回声,6例(32%)为低回声;15例(79%)边界清晰,16例(84%)形态不规则; 19例(100%)右心房癌栓内未见血流信号; 12例(63%)右心房癌栓随心动周期活动,活动规律与心动周期无关,7例(37%)右心房癌栓随心动周期活动不明显; 3例(16%)累及右室流入道;本组患者发现右心房肿瘤转移后生存时间为25～412天,其中2例患者出现急性肺栓塞。结论肝静脉-下腔静脉-右心房或下腔静脉-右心房连续性癌栓是本病最重要的超声表现,本病患者生存时间短,可并发急性肺栓塞而死亡。

关键词: 肝细胞癌, 心脏转移, 超声表现, 预后

Abstract: Objective The ultrasonographic feature and prognosis of patients with hepatocellular carcinoma (HCC) and cardiac metastasis were summarized. Methods A total of 19 patients with HCC and cardiac metastasis were admitted to our hospital between January 2013 and May 2019, and all patients underwent ultrasonography and followed-up for 12 months. The diagnosis was confirmed by histopathological examination. Results The solid echo was observed in adjacent hepatic veins and extended to inferior vena cava and right atrium in 16 cases (84%), the solid echogenicity was observed in adjacent inferior vena cava and extended to right atrium in 3 cases (16%), the mixed echo was found in 13 cases (68%) and the hypoechoic in 6 cases (32%); the clear boundaries was found in 15 cases (79%) and the irregular morphology was found in 16 cases (89%); there was no blood flow signal of tumor thrombus in the right atrial in 19 cases (100%); no relationship with cardiac cycle was found in 12 cases 63%, and no significant relationship with cardiac cycle was found in 7 cases (37%); the right ventricular inflow tract was involved in 3 cases (16%); the survival time after right atrial metastasis was found was 25 to 412 days, and acute pulmonary embolism was found in 2 patients. Conclusion The continuous cancerous thrombus extending from hepatic vena to inferior vena cava to right atrium or to inferior vena cava to right atrium is the most important ultrasonographic manifestations in patients with HCC and cardiac metastasis. The patients at this circumstance have a very short survival time and might have acute pulmonary embolism at any time.

Key words: Hepatoma, Cardiac metastasis, Ultrasound, Prognosis

王连双, 张瑶, 单涛, 张记, 吕志斌, 薛明. 19例原发性肝癌心脏转移患者超声特征表现和预后分析^*[J]. 实用肝脏病杂志, 2022, 25(2): 271-274.

Wang Lianshuang, Zhang Yao, Shan Tao, et al. Ultrasonographic feature and prognosis of patients with hepatocellular carcinaoma and cardiac metastases: Analysis of 19 cases[J]. Journal of Practical Hepatology, 2022, 25(2): 271-274.

参考文献

[1] 原发性肝癌诊疗规范(2019年版).中华肝脏病杂志,2020,28(2):112-128.
[2] Luo X, Zhang B,Dong S,et al. Hepatocellular carcinoma with tumor thrombus occupying the right atrium and portal vein: A case report and literature review. Medicine,2015,94(34):e1049.
[3] Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging, 2015,16(3):233-270.
[4] Pandya H,Shah C,Lakhani J,et al.Intra-atrial tumour thrombus secondary to hepatocellular carcinoma. Australas Med J, 2013,6(6):321-324.
[5] El-Serag HB, Davila JA. Surveillance for hepatocellular carcinoma:in whom and how? Therap Adv Gastroenterol,2011,4(1):5-10.
[6] Narang-Master J,Rizzolo D.Managing localized unresectable hepatocellular carcinoma. JAAPA,2015,28(1):27-34.
[7] Jun CH,Sim DW,Kim SH,et al. Risk factors for patients with stage IVB hepatocellular carcinoma and extension into the heart: prognostic and therapeutic implications.Yonsei Med J, 2014,55(2):379-386.
[8] Ohta M,Nakanishi C,Kawagishi N,et al.Surgical resection of recurrent extrahepatic hepatocellular carcinoma with tumor thrombus extending into the right atrium under cardiopulmonary bypass: a case report and review of the literature. Surg Case Rep,2016,2:110.
[9] Albackr HB.A large right atrial mass in a patient with hepatocellular carcinoma: case report and literature review. J Saudi Heart Assoc,2014,26(3):174-178.
[10] Chen MH, Huang XN, Yang QY.Hepatocellular carcinoma with inferior vena cava and right atrial tumor thrombus: A case report.Echocardiography,2019,36(11):2110-2113.
[11] Lourenço LC, Horta DV, Alberto SF, et al.Hepatocellular carcinoma presenting with Budd-Chiari syndrome,right atrial thrombus and pulmonary emboli. Patologia Digestiva,2017,109(4):296-297.
[12] Chang JY, Ka WS, Chao TY.Hepatocellular carcinoma with intra-atrial tumor thrombi. A report of three cases responsive to thalidomide treatment and literature review.Oncology,2004,67(3-4):320-326.
[13] Leong K, Kuppasani K, Pyrsopoulos N.Atrial tumor thrombus: A rare complication of hepatocellular carcinoma.JAAPA, 2019,32(2):23-26.
[14] Vallakati A,Chandra PA,Frankel R,et al. Intra-atrial tumor thrombi secondary to hepatocellular carcinoma responding to chemotherapy. N Am J Med Sci, 2011,3(9):435-437.
[15] Hayashida K, Okumura S, Kawase T. Right atrial obstruction due to cardiac extension of hepatocellular carcinoma. Asian Cardiovasc Thorac Ann, 2014,22(4):465-468.
[16] Sun JH,Zhang YL,Nie CH,et al.Long-term survival after chemoembolization of metastatic right atrial tumor thrombus as a presenting feature of hepatocellular carcinoma: a case study.Oncol Lett, 2012,3(5):975-977.
[17] Florman S,Weaver M,Primeaux P,et al. Aggressive resection of hepatocellular carcinoma with right atrial involvement. Am Surg,2009,75:1104–1108.
[18] Fukuda S,Okuda K,Imamura M, et al.Surgical resection combined with chemotherapy for advanced hepatocellular carcinoma with tumor thrombus: report of 19 cases. Surgery, 2002,131:300-310.
[19] Ohwada S,Takahashi T,Tsutsumi H,et al.Hepatocellular carcinoma with a tumour thrombus extending to the tricuspid valve:report of a successful en bloc resection. Hepatogastroenterology,2008,55:903-906.
[20] Wang Y, Yuan L, Ge RL,et al. Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: results of a retrospective cohort study. Ann Surg Oncol,2013,20:914-922.
[21] Wakayama K, Kamiyama T, Yokoo H,et al. Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium. World J Surg Oncol,2013,11:259.

19例原发性肝癌心脏转移患者超声特征表现和预后分析^*

Ultrasonographic feature and prognosis of patients with hepatocellular carcinaoma and cardiac metastases: Analysis of 19 cases

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨蕊旭, 范建高. 非酒精性脂肪性肝病相关肝细胞癌流行病学与筛查^*[J]. 实用肝脏病杂志, 2022, 25(2): 153-156.
[2]	郑小勤, 徐辉, 李丽, 靳华, 汪晓军, 勾春燕. 家族聚集性原发性胆汁性肝硬化患者临床特征分析[J]. 实用肝脏病杂志, 2022, 25(2): 207-210.
[3]	王欣然, 蒋燕东, 张猛. 超声引导下放射性粒子植入治疗肝细胞癌患者短期疗效研究^*[J]. 实用肝脏病杂志, 2022, 25(2): 263-266.
[4]	余涛, 付路路, 陈方, 田园. 超声造影灌注时相分析在肝硬化背景下对肝脏增生结节的诊断价值[J]. 实用肝脏病杂志, 2022, 25(2): 267-270.
[5]	李欢, 李扬, 杜娟, 梅放, 王玉湘, 郭丽梅. 肝细胞癌组织Glypican3和Sonic Hedgehog蛋白表达及其功能分析^*[J]. 实用肝脏病杂志, 2022, 25(1): 83-87.
[6]	肖倩, 周展, 胡小丽. 肝细胞癌患者肝内病灶超声造影参数变化^*[J]. 实用肝脏病杂志, 2022, 25(1): 92-95.
[7]	何胜夫, 汪保灿, 范建高, 汪余勤. 胆源性肝损伤临床特征分析及治疗手段探讨[J]. 实用肝脏病杂志, 2022, 25(1): 100-103.
[8]	中国肝炎防治基金会肝细胞癌筛查和监测项目专家组. 慢性乙型肝炎病毒感染者肝细胞癌筛查和监测[J]. 实用肝脏病杂志, 2021, 24(6): 776-785.
[9]	贾坤, 苏建荣, 孙伟. 慢性丙型肝炎患者血清和外泌体LncRNA HEIH水平及其临床意义探讨^*[J]. 实用肝脏病杂志, 2021, 24(6): 823-826.
[10]	华琪, 陈琦, 游览. 142例抗结核药物性肝损伤患者临床特征分析^*[J]. 实用肝脏病杂志, 2021, 24(6): 843-846.
[11]	刘积庆, 于国英, 杨生森, 黄群, 保成兰. 多种预后评分系统预测慢加急性肝衰竭并发真菌感染患者短期预后价值分析^*[J]. 实用肝脏病杂志, 2021, 24(6): 851-854.
[12]	吴慧娟, 何年安, 谢蠡, 叶显俊, 章生龙, 刘力. 超声造影联合血清CA19-9鉴别诊断胆管细胞癌与肝细胞癌应用研究[J]. 实用肝脏病杂志, 2021, 24(6): 903-906.
[13]	周正, 刘玮. 肝血管瘤、肝细胞癌和肝血管平滑肌脂肪瘤超声造影特点观察^*[J]. 实用肝脏病杂志, 2021, 24(6): 911-914.
[14]	赵鹏飞, 祖红梅, 辛晓恩, 彭军宁, 严兆兰, 马存凯, 李雅静, 杨硕. 肝细胞癌发病危险因素Logistic回归分析^*[J]. 实用肝脏病杂志, 2021, 24(6): 927-929.
[15]	管海燕, 杨文斌. 药物性肝损伤患者临床特点及预后分析^*[J]. 实用肝脏病杂志, 2021, 24(5): 713-716.